SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000919574-20-005961
Filing Date
2020-09-23
Accepted
2020-09-23 10:37:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8617859_13d-a.htm SC 13D/A 101093
  Complete submission text file 0000919574-20-005961.txt   102667
Mailing Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540 609-419-1800
CAXTON CORP (Filed by) CIK: 0001388551 (see all company filings)

IRS No.: 222437619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Subject) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: SC 13D/A | Act: 34 | File No.: 005-89153 | Film No.: 201191174
SIC: 2834 Pharmaceutical Preparations